Description
PLASMA
First action · last action
2020-08-19 · 2025-08-19
Transactions
2
First transaction's obligation
$825,300
Base + all options value (sum of deltas)
$1,663,800
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24E20D0027
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-08-19+$825,300= $825,300
- Mod P000012025-08-19-$15,900= $809,400
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-08-19 | +$825,300 | $825,300 | PLASMA |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-08-19 | −$15,900 | $809,400 | PLASMA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GKT4L2JZJ622)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026D0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $0 | FY2026 |
| 36C26026N0391 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $70,000 | FY2026 |
| 36C24426N0344 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $1,682,246 | FY2026 |
| 36C24426D0025 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24426N0788 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $56,268 | FY2026 |
| 36C26126N0359 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $123,337 | FY2026 |
Other recipients under 6505 from RPO EAST (36C24E) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24E20N0134 | UNIVERSITY OF MARYLAND, BALTIMORE | RPO EAST (36C24E) | $503,500 | FY2020 |
| 36C24E20N0038 | UNIVERSITY OF MARYLAND, BALTIMORE | RPO EAST (36C24E) | $576,000 | FY2020 |
| 36C24E19N0047 | UNIVERSITY OF MARYLAND, BALTIMORE | RPO EAST (36C24E) | $764,800 | FY2019 |
| 36C24E18N0046 | UNIVERSITY OF MARYLAND, BALTIMORE | RPO EAST (36C24E) | $408,000 | FY2018 |
| VA24017P0415 | EMD MILLIPORE CORP | RPO EAST (36C24E) | $13,227 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24E20N0126_3600_36C24E20D0027_3600 · retrieved 2026-09-26.